These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
180 related items for PubMed ID: 21393187
21. Detection of macrolide resistance in Streptococcus pneumoniae. Kimura T, Horii T, Morita M, Muramatsu H, Kanno T, Maekawa M. Chemotherapy; 2003 May; 49(1-2):56-61. PubMed ID: 12714812 [Abstract] [Full Text] [Related]
24. Trends in the activity of macrolide and beta-lactam antibiotics and resistance development. Alexander Project Group. Schito GC, Mannelli S, Pesce A. J Chemother; 1997 May; 9 Suppl 3():18-28. PubMed ID: 9248977 [Abstract] [Full Text] [Related]
25. Fluoroquinolone and macrolide treatment failure in pneumococcal pneumonia and selection of multidrug-resistant isolates. Pérez-Trallero E, Marimon JM, Iglesias L, Larruskain J. Emerg Infect Dis; 2003 Sep; 9(9):1159-62. PubMed ID: 14519256 [Abstract] [Full Text] [Related]
26. Antimicrobial susceptibility of Streptococcus pneumoniae at a university hospital in Taiwan, 2000-07: impact of modified non-meningeal penicillin breakpoints in CLSI M100-S18. Su LH, Wu TL, Kuo AJ, Chia JH, Chiu CH. J Antimicrob Chemother; 2009 Aug; 64(2):336-42. PubMed ID: 19520718 [Abstract] [Full Text] [Related]
27. Evolution of macrolide resistance in Streptococcus pneumoniae clinical isolates in the prevaccine era. Daikos GL, Koutsolioutsou A, Tsiodras S, Theodoridou M, Koutouzis EI, Charissiadou A, Pangalis A, Michos AG, Chaidopoulou F, Braoudaki M, Syriopoulou VP. Diagn Microbiol Infect Dis; 2008 Apr; 60(4):393-8. PubMed ID: 18077121 [Abstract] [Full Text] [Related]
28. Novel penicillin-, cephalosporin-, and macrolide-resistant clones of Streptococcus pneumoniae serotypes 23F and 19F in Taiwan which differ from international epidemic clones. Chiou CC, McEllistrem MC. J Clin Microbiol; 2001 Mar; 39(3):1144-7. PubMed ID: 11230444 [Abstract] [Full Text] [Related]
29. Efficacy of beta-lactams against experimental pneumococcal endocarditis caused by strains with different susceptibilities to penicillin. Pichardo C, Docobo-Pérez F, Pachón-Ibáñez ME, Jiménez-Mejías ME, García-Curiel A, Caballero-Granado FJ, Moreno-Maqueda I, Pachón J. J Antimicrob Chemother; 2005 Oct; 56(4):732-7. PubMed ID: 16150863 [Abstract] [Full Text] [Related]
34. In vitro activities of ertapenem against drug-resistant Streptococcus pneumoniae and other respiratory pathogens from 12 Asian countries. Song JH, Ko KS, Lee MY, Park S, Baek JY, Lee JY, Heo ST, Kwon KT, Ryu SY, Oh WS, Peck KR, Lee NY. Diagn Microbiol Infect Dis; 2006 Dec; 56(4):445-50. PubMed ID: 16949783 [Abstract] [Full Text] [Related]
38. Macrolide resistance determinants in erythromycin-resistant Streptococcus pneumoniae in Turkey. Gulay Z, Ozbek OA, Bicmen M, Gur D. Jpn J Infect Dis; 2008 Nov; 61(6):490-3. PubMed ID: 19050364 [Abstract] [Full Text] [Related]
39. TARGETed surveillance: susceptibility of Streptococcus pneumoniae isolated from community-acquired respiratory tract infections in 2003 to fluoroquinolones and other agents. Morrissey I, Colclough A, Northwood J. Int J Antimicrob Agents; 2007 Oct; 30(4):345-51. PubMed ID: 17643269 [Abstract] [Full Text] [Related]
40. The clinical significance of macrolide-resistant Streptococcus pneumoniae: it's all relative. Nuermberger E, Bishai WR. Clin Infect Dis; 2004 Jan 01; 38(1):99-103. PubMed ID: 14679455 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]